Cardiovascular Risk in Patients with Early Renal Insufficiency

[1]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[2]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[3]  G. Reboldi,et al.  High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. , 2001, Archives of internal medicine.

[4]  A. Zanchetti,et al.  Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.

[5]  J. Pogue,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[6]  J. Yee,et al.  Risks associated with renal dysfunction in patients in the coronary care unit. , 2000, Journal of the American College of Cardiology.

[7]  Colin Baigent,et al.  Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.

[8]  G. Bakris,et al.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? , 2000, Archives of internal medicine.

[9]  Bruce H. R. Wolffenbuttel,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.

[10]  D. Levy,et al.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.

[11]  Z. Massy,et al.  Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  G. Remuzzi,et al.  Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial , 1998, The Lancet.

[13]  A R Nissenson,et al.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. , 1998, The New England journal of medicine.

[14]  G. Pacini,et al.  Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. , 1998, Kidney international.

[15]  S. Wannamethee,et al.  Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. , 1997, Stroke.

[16]  E. Ritz,et al.  Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. , 1996, Kidney international.

[17]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[18]  G. Malcom,et al.  Nephrosclerosis, glycohemoglobin, cholesterol, and smoking in subjects dying of coronary heart disease. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[19]  J. Neaton,et al.  Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  B. Kasiske.  Relationship between vascular disease and age-associated changes in the human kidney. , 1987, Kidney international.

[21]  A. Gray.  Decamethonium iodide as a muscle relaxant in abdominal surgery. , 1950, Lancet.

[22]  F. Kronenberg,et al.  Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. , 2000, Journal of the American Society of Nephrology : JASN.